Helixgate

Helixgate

Uncategorized

Live: Senate committee questions NIH director on 2027 budget

National Institutes of Health Director Jay Bhattacharya is appearing in front of the Senate Appropriations Committee Wednesday, starting at 10 a.m. ET, to discuss President Trump’s budget proposal for the 2027 fiscal year. 

That budget, released in April, proposed cutting the agency’s budget by $5 billion and eliminating five of its 27 institutes. Those proposals are unlikely to be enacted, given lawmakers’ strong rebuke of Trump’s 2026 proposal, which called for even steeper cuts. While the most drastic proposals have not manifested, the biomedical research community is still under intense stress. 

Read the rest…

Read More

Published

on

National Institutes of Health Director Jay Bhattacharya is appearing in front of the Senate Appropriations Committee Wednesday, starting at 10 a.m. ET, to discuss President Trump’s budget proposal for the 2027 fiscal year. 

That budget, released in April, proposed cutting the agency’s budget by $5 billion and eliminating five of its 27 institutes. Those proposals are unlikely to be enacted, given lawmakers’ strong rebuke of Trump’s 2026 proposal, which called for even steeper cuts. While the most drastic proposals have not manifested, the biomedical research community is still under intense stress. 

Read the rest…

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Amgen shores up Tavneos’ FDA defense with Duke data analysis

Amgen shores up Tavneos’ FDA defense with Duke data analysis

Published

on

After the FDA flagged patient deaths linked to Amgen’s rare disease drug Tavneos and called for its voluntary removal, the pharma recruited an independent data analysis from Duke researchers to help build the case for the drug’s continued market approval.​ ​Read More

Continue Reading

Uncategorized

Chile offers new data on food warning label efficacy

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

So much news today that I didn’t have space to write an item about hot tubs as a breeding ground for Legionnaires’ disease. Here’s the CDC report, if you’re curious.

Read the rest…

Read More

Published

on

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

So much news today that I didn’t have space to write an item about hot tubs as a breeding ground for Legionnaires’ disease. Here’s the CDC report, if you’re curious.

Read the rest…

Read More

Continue Reading

Uncategorized

Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win

Published

on

The RNA-based medicine is one of a handful of antibody-oligonucleotide conjugates that Novartis acquired last October when it took over neuromuscular-focused Avidity Biosciences.

Continue Reading
Advertisement

Trending